4//SEC Filing
Lu Timothy K 4
Accession 0001854270-24-000015
CIK 0001854270other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:27 PM ET
Size
9.5 KB
Accession
0001854270-24-000015
Insider Transaction Report
Form 4
Lu Timothy K
DirectorCEO and Interim PFO and PAO
Transactions
- Award
Common Stock
2024-02-01+306,000→ 865,496 total - Award
Stock Option (Right to Buy)
2024-02-01+459,000→ 459,000 totalExercise: $0.46Exp: 2034-01-31→ Common Stock (459,000 underlying)
Holdings
- 528,390(indirect: See footnote)
Common Stock
- 528,390(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.
- [F2]The shares are held by Luminen Services, LLC, as trustee of the Luminen Trust, of which the reporting person is the settlor. The reporting person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F3]The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Senti Biosciences, Inc.
CIK 0001854270
Entity typeother
Related Parties
1- filerCIK 0001852301
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:27 PM ET
- Size
- 9.5 KB